Breaking newsCOVID-19Research
Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids
Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids
The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019 according to a new study within the EAN-led Cost of Illness in Neurology in Europe (COIN-Eu) initiative.
Latest Posts
-
-
Breaking newsCOVID-19ResearchHuman neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection -
Breaking newsCOVID-19Research
Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell derived lung and cerebral organoids
Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell derived lung and cerebral organoids -
Breaking newsCOVID-19Research
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera -
The antigenic anatomy of SARS-CoV-2 receptor binding domain
-
Breaking newsCOVID-19Research
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera -
Breaking newsCOVID-19Research
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape -
Assessing the influence of climate on wintertime SARS-CoV-2 outbreaks
-
Breaking newsCOVID-19Research
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants -
Reduction in mobility and COVID-19 transmission
-
Breaking newsCOVID-19ResearchGlobal absence and targeting of protective immune states in severe COVID-19
Global absence and targeting of protective immune states in severe COVID-19 -
Breaking newsCOVID-19Research
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study -
Breaking newsCOVID-19ResearchEffect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial -
Breaking newsCOVID-19ResearchEffect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial
Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial -
Alzheimer Europe continues to develop and improve its Clinical Trials Watch (CTW), an innovative online resource providing up-to-date accessible information on clinical trials currently recruiting participants in a least one European country.